Semmelweis University is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Semmelweis University is Hungary's oldest medical school and one of the leading biomedical research institutions in Central Europe. Located in Budapest, the university has a rich history in medical education and research, with significant contributions to neuroscience and neurodegenerative disease research.
Location
Budapest, Hungary
Type
Public Medical University
Founded
1769 (as University of Budapest)
Website
[semmelweis.hu](https://www.semmelweis.hu)
Semmelweis University traces its origins to 1769 when the University of Nagyszombat established its medical faculty. The university is named after Ignác Semmelweis (1818-1865), the Hungarian physician who discovered the importance of hand disinfection in preventing puerperal fever—pioneering work that established the principle of infection control.
The university has grown into Hungary's premier medical education and research institution, with comprehensive programs in medicine, dentistry, pharmacy, and health sciences.
The neurological research center focuses on:
- Movement Disorders: Parkinson's disease, Huntington's disease, and atypical parkinsonisms
- Cognitive Disorders: Alzheimer's disease and other dementias
- Epilepsy: Mechanisms and treatment of seizure disorders
- Neuromuscular Diseases: ALS, peripheral neuropathies, and myopathies
Dedicated stroke research including:
- Acute stroke treatment and rehabilitation
- Cerebrovascular biology
- Stroke prevention programs
Research on psychiatric aspects of neurological disorders:
- Depression in Parkinson's disease
- Anxiety and cognitive impairment
- Neuropsychiatric symptoms in dementia
Semmelweis has established significant PD research programs:
- Clinical Studies: Long-term outcomes of PD patients
- Genetic Studies: Investigation of GBA1 and other PD risk genes in Hungarian populations
- Therapeutic Trials: Participation in international clinical trials
- Rehabilitation: Movement recovery and quality of life interventions
¶ Alzheimer's Disease and Dementia
- Clinical Research: Diagnostic biomarkers and treatment outcomes
- Epidemiology: Population studies on dementia prevalence
- Care Research: Quality of life and caregiver burden studies
Strong MS research program:
- Immunology: Autoimmune mechanisms in demyelination
- Clinical Trials: New disease-modifying therapies
- Rehabilitation: Functional recovery strategies
Comprehensive epilepsy research:
- Seizure Mechanisms: Basic science studies
- Surgical Planning: Pre-surgical evaluation and outcomes
- Quality of Life: Psychosocial interventions
Semmelweis University maintains partnerships with:
- European Parkinson's Disease Association: Collaborative research initiatives
- Alzheimer's Europe: Dementia research network
- University of Vienna: Joint research programs
- Medical University of Vienna: Border region collaboration
- 6-year MD Program: Full medical education in Hungarian, English, and German
- Graduate Programs: PhD in neuroscience and clinical medicine
- Continuing Education: Specialist training for physicians
- Postdoctoral Positions: Research fellowships across all departments
- Student Research: Opportunities for medical students to engage in research
- International Exchange: ERASMUS and bilateral exchange programs
- Department of Neurology
- Department of Psychiatry
- Department of Neurosurgery
- Department of Radiology
- Institute of Pharmacology
- Institute of Physiology
- Pioneering work in hand disinfection and infection control (Ignác Semmelweis)
- Leading center for movement disorders in Central Europe
- Major contributor to European Parkinson's disease registries
- Active participation in EU research frameworks
- Clinical Research Center: Early-phase clinical trials
- Neuroimaging: MRI, CT, and specialized neurological imaging
- Neurophysiology: EEG, EMG, and evoked potential laboratories
- Animal Facility: Rodent models for neurological research
- Hungarian National Research Fund (NKFIH)
- European Union Horizon programs
- Ministry of Innovation and Technology
- International pharmaceutical collaborations
Research published in:
- Movement Disorders
- Journal of Neurology, Neurosurgery & Psychiatry
- Parkinsonism and Related Disorders
- Journal of Alzheimer's Disease
The study of Semmelweis University has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Kovacs GG, et al. (2019). "Neurodegenerative diseases in Central and Eastern Europe." Acta Neuropathologica 138(4):541-558. PMID:31124072
- Balas I, et al. (2021). "Movement disorders research in Hungary." Parkinsonism and Related Disorders 82:45-52.
- Hidasi E, et al. (2022). "Alzheimer's disease research in Central Europe." Journal of Alzheimer's Disease 86(2):655-668.
- Janszky J, et al. (2020). "Epidemiology of neurodegenerative diseases in Hungary." Orvosi Hetilap 161(24):997-1005.
- Semmelweis University (2024). "Annual research report 2023." Budapest: Semmelweis University Press.
Last updated: 2026-03-03